Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 18
195
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Three new proaporphine alkaloids from Cissampelos capensis L.f. and their cytotoxic evaluation

& ORCID Icon
Pages 3065-3073 | Received 07 Jun 2022, Accepted 03 Nov 2022, Published online: 16 Nov 2022
 

Abstract

Three new proaporphine alkaloids, cissamaline (4), cissamanine (5), and cissamdine (6), along with two known compounds (2 and 3) were isolated from total tertiary alakloidal extracts of the leaves and stems of Cissampelos capensis. The new alkaloids were elucidated through comprehensive spectroscopic analysis, including 1 D, 2 D NMR and High-resolution LCMS. The in vitro MTT cytotoxicity was evaluated on Caco-2 cell lines, where all the isolated compounds exhibited cytotoxic effects at concentrations above 250 µM.

Graphical Abstract

Acknowledgments

The authors acknowledge their biochemistry collaborators, Prof M van de Venter and Ms S Reddy, plant collection by Mr J Block, and the Herbarium at Nelson Mandela University for authentication of plant species.

Disclosure statement

No potential conflicts of interest were reported by the authors.

Additional information

Funding

This work was funded by the Nelson Mandela University Research Development and student support by the National Research Fund (NRF) of South Africa Scares Skills Scholarship [grant number 108391].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.